Humoral immune-response to a SARS-CoV-2-BNT162b2 booster in inflammatory arthritis patients who received an inactivated virus vaccine.

Josefina DuránPaula Isabel BurgosNicole Le CorreCinthya Ruiz TagleConstanza Martinez-ValdebenitoMauricio CastroValentina MetcalfePaula NiemannM Elvira Balcells

Published in: Annals of the rheumatic diseases (2022)

Keyphrases

immune response
sars cov
rheumatoid arthritis
respiratory syndrome coronavirus
oxidative stress
dendritic cells
toll like receptor
disease virus
coronavirus disease